The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
β2 adrenergic receptor–mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells
Open accessAbstract
Catecholamines released by sympathetic nerves can activate adrenergic receptors present on nearly every cell type, including myeloid-derived suppressor cells (MDSCs). Using in vitro systems, murine tumor models in wild-type and genetically modified (β2-AR-/-) mice, and adoptive transfer approaches, we found that the degree of β2-AR signaling significantly influences MDSC frequency and survival in tumors and other tissues. It also modulates their expression of immunosuppressive molecules such as arginase-I and PD-L1 and alters their ability to suppress the proliferation of T cells. The regulatory functions of β2-AR signaling in MDSCs were also found to be dependent upon STAT3 phosphorylation. Moreover, we observed that the β2-AR-mediated increase in MDSC survival is dependent upon Fas-FasL interactions, and this is consistent with gene expression analyses, which reveal a greater expression of apoptosis-related genes in β2-AR-/- MDSCs. Our data reveal the potential of β2-AR signaling to increase the generation of MDSCs from both murine and human peripheral blood cells and that the immunosuppressive function of MDSCs can be mitigated by treatment with β-AR antagonists, or enhanced by β-AR agonists. This strongly supports the possibility that reducing stress-induced activation of β2-ARs could help to overcome immune suppression and enhance the efficacy of immunotherapy and other cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kamiya, A., Hayama, Y., Kato, S., Shimomura, A., Shimomura, T., Irie, K., Kaneko, R., Yanagawa, Y., Kobayashi, K., & Ochiya, T. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0430-3 · Cited by 288
RetractedRecommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Bronte, V., Brandau, S., Chen, S.-H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12150 · Cited by 2,751
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
Deng, L., Liang, H., Burnette, B., Beckett, M., Darga, T., Weichselbaum, R. R., & Fu, Y.-X. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67313 · Cited by 2,105
Myeloid-Derived Suppressor Cells
Gabrilovich, D. I. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0297 · Cited by 1,882
Myeloid-derived suppressor cells coming of age
Veglia, F., Perego, M., & Gabrilovich, D. (2018) · Nature Immunology · doi:10.1038/s41590-017-0022-x · Cited by 1,767
Autonomic nerve development contributes to prostate cancer progression
Magnon, C., Hall, S. J., Lin, J., Xue, X., Gerber, L., Freedland, S. J., & Frenette, P. S. (2013) · Science · doi:10.1126/science.1236361 · Cited by 1,287
Structure-Function of the G Protein–Coupled Receptor Superfamily
Katritch, V., Cherezov, V., & Stevens, R. C. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032112-135923 · Cited by 1,054
The sympathetic nervous system induces a metastatic switch in primary breast cancer
Sloan, E. K., Priceman, S. J., Cox, B. F., Yu, S., Pimentel, M. A., Tangkanangnukul, V., Arevalo, J. M. G., Morizono, K., Karanikolas, B. D. W., Wu, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0522 · Cited by 930
Possible involvement of the M2 anti‐inflammatory macrophage phenotype in growth of human gliomas
Komohara, Y., Ohnishi, K., Kuratsu, J., & Takeya, M. (2008) · The Journal of Pathology · doi:10.1002/path.2370 · Cited by 738
Molecular Pathways: Beta-Adrenergic Signaling in Cancer
Cole, S. W., & Sood, A. K. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0641 · Cited by 681
Blaskovich, M. A., Sun, J., Cantor, A. B., Turkson, J., Jove, R., & Sebti, S. M. (2003) · PubMed · Cited by 643
Lechner, M. G., Liebertz, D. J., & Epstein, A. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000901 · Cited by 582
Sympathetic nervous system regulation of the tumour microenvironment
Cole, S. W., Nagaraja, A. S., Lutgendorf, S. K., Green, P. A., & Sood, A. K. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3978 · Cited by 576 · cited 1×
“org Volume 129 Number 12 December 2019 are also mediated through the sympathetic nervous system and adrenergic signaling (14, 41).”
BackgroundUgel, S., De Sanctis, F., Mandruzzato, S., & Bronte, V. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80006 · Cited by 559
Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
Condamine, T., Ramachandran, I., Youn, J.-I., & Gabrilovich, D. I. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-051013-052304 · Cited by 521
Impact of Stress on Cancer Metastasis
Moreno-Smith, M., Lutgendorf, S. K., & Sood, A. K. (2010) · Future Oncology · doi:10.2217/fon.10.142 · Cited by 510
Ostrand-Rosenberg, S., & Fenselau, C. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701019 · Cited by 509
Kumar, V., Cheng, P., Condamine, T., Mony, S., Languino, L. R., McCaffrey, J. C., Hockstein, N., Guarino, M., Masters, G., Penman, E., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.01.014 · Cited by 371
Kokolus, K. M., Capitano, M. L., Lee, C.-T., Eng, J. W.-L., Waight, J. D., Hylander, B. L., Sexton, S., Hong, C.-C., Gordon, C. J., Abrams, S. I., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304291110 · Cited by 335
Self-citationMyeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis
Waight, J. D., Netherby, C., Hensen, M. L., Miller, A., Hu, Q., Liu, S., Bogner, P. N., Farren, M. R., Lee, K. P., Liu, K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68189 · Cited by 323
Self-citationThermal physiology of laboratory mice: Defining thermoneutrality
Gordon, C. J. (2012) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2012.08.004 · Cited by 305
Bucsek, M. J., Qiao, G., MacDonald, C. R., Giridharan, T., Evans, L., Niedzwecki, B., Liu, H., Kokolus, K. M., Eng, J. W.-L., Messmer, M. N., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0546 · Cited by 294
Self-citationNerve–Cancer Cell Cross-talk: A Novel Promoter of Tumor Progression
Jobling, P., Pundavela, J., Oliveira, S. M. R., Roselli, S., Walker, M. M., & Hondermarck, H. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3180 · Cited by 272 · cited 1×
“Nerve fibers present in and around most tissues and organs, as well as tumors (13, 16, 17), release neurotransmitters and other neuropeptides locally and systemically.”
BackgroundTumor Neurobiology and the War of Nerves in Cancer
Faulkner, S., Jobling, P., March, B., Jiang, C. C., & Hondermarck, H. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1398 · Cited by 267
Neural Regulation of Hematopoiesis, Inflammation, and Cancer
Hanoun, M., Maryanovich, M., Arnal-Estapé, A., & Frenette, P. S. (2015) · Neuron · doi:10.1016/j.neuron.2015.01.026 · Cited by 265
Apoptosis signaling pathways and lymphocyte homeostasis
Xu, G., & Shi, Y. (2007) · Cell Research · doi:10.1038/cr.2007.52 · Cited by 243
The beta2-adrenergic receptor on T and B lymphocytes: Do we understand it yet?
Sanders, V. M. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.08.001 · Cited by 235
He, Y.-M., Li, X., Perego, M., Nefedova, Y., Kossenkov, A. V., Jensen, E. A., Kagan, V., Liu, Y.-F., Fu, S.-Y., Ye, Q.-J., et al. (2018) · Nature Medicine · doi:10.1038/nm.4467 · Cited by 223
Lorton, D., & Bellinger, D. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16035635 · Cited by 221
Morales, J. K., Kmieciak, M., Knutson, K. L., Bear, H. D., & Manjili, M. H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0622-8 · Cited by 214
Kokolus, K. M., Zhang, Y., Sivik, J. M., Schmeck, C., Zhu, J., Repasky, E. A., Drabick, J. J., & Schell, T. D. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1405205 · Cited by 200 · cited 1×
“This point is reinforced by recent epidemiological data coming from several different cancer settings, supporting the idea that daily use of β-blockers, for indications unrelated to cancer, is associated with improved response to therapy and increased overall survival (44).”
ResultSelf-citationEng, J. W.-L., Kokolus, K. M., Reed, C. B., Hylander, B. L., Ma, W. W., & Repasky, E. A. (2014) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-014-1617-9 · Cited by 189
Self-citationModulation of anti-tumor immunity by the brain’s reward system
Ben-Shaanan, T. L., Schiller, M., Azulay-Debby, H., Korin, B., Boshnak, N., Koren, T., Krot, M., Shakya, J., Rahat, M. A., Hakim, F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05283-5 · Cited by 171
Eng, J. W. ‐., Reed, C. B., Kokolus, K. M., Pitoniak, R., Utley, A. T., Bucsek, M. J., Ma, W. W., Repasky, E. A., & Hylander, B. L. (2015) · Nature Communications · doi:10.1038/ncomms7426 · Cited by 169
Self-citationAdrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response
Qiao, G., Chen, M., Bucsek, M. J., Repasky, E. A., & Hylander, B. L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00164 · Cited by 168
Self-citationSinha, P., Chornoguz, O., Clements, V. K., Artemenko, K. A., Zubarev, R. A., & Ostrand‐Rosenberg, S. (2011) · Blood · doi:10.1182/blood-2010-11-321752 · Cited by 158
Social Stress Mobilizes Hematopoietic Stem Cells to Establish Persistent Splenic Myelopoiesis
McKim, D. B., Yin, W., Wang, Y., Cole, S. W., Godbout, J. P., & Sheridan, J. F. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.102 · Cited by 153
Role of the nervous system in cancer metastasis
Kuol, N., Stojanovska, L., Apostolopoulos, V., & Nurgali, K. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0674-x · Cited by 153
Neuroendocrine influences on cancer progression
Armaiz-Pena, G. N., Cole, S. W., Lutgendorf, S. K., & Sood, A. K. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.005 · Cited by 145 · cited 1×
“Nerve fibers present in and around most tissues and organs, as well as tumors (13, 16, 17), release neurotransmitters and other neuropeptides locally and systemically.”
BackgroundSTAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity
Su, Y., Banerjee, S., White, S. V., & Kortylewski, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061803 · Cited by 131
Sympathetic Neuronal Activation Triggers Myeloid Progenitor Proliferation and Differentiation
Vasamsetti, S. B., Florentin, J., Coppin, E., Stiekema, L. C. A., Zheng, K. H., Nisar, M. U., Sembrat, J., Levinthal, D. J., Rojas, M. M., Stroes, E. S. G., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.05.004 · Cited by 124
Myeloid derived-suppressor cells: their role in cancer and obesity
Ostrand‐Rosenberg, S. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.03.007 · Cited by 123
Estrada, L. D., Ağaç, D., & Farrar, J. D. (2016) · European Journal of Immunology · doi:10.1002/eji.201646395 · Cited by 116
Kokolus, K. M., Spangler, H., Povinelli, B. J., Farren, M. R., Lee, K. P., & Repasky, E. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00023 · Cited by 68
Self-citationHu, X., Bardhan, K., Paschall, A. V., Yang, D., Waller, J. L., Park, M. A., Nayak-Kapoor, A., Samuel, T. A., Abrams, S. I., & Liu, K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.434530 · Cited by 67
Self-citationSchmidt, D., Peterlik, D., Reber, S. O., Lechner, A., & Männel, D. N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159059 · Cited by 66
Weiss, J. M., Subleski, J. J., Back, T., Chen, X., Watkins, S. K., Yagita∥, H., Sayers, T. J., Murphy, W. J., & Wiltrout, R. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400404 · Cited by 63
Leigh, N. D., Kokolus, K. M., O’Neill, R., Du, W., Eng, J. W. ‐., Qiu, J., Chen, G. L., McCarthy, P. L., Farrar, J. D., Cao, X., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500700 · Cited by 60
Self-citationEpigenetic regulation of beta2-adrenergic receptor expression in TH1 and TH2 cells
McAlees, J. W., Smith, L. T., Erbe, R. S., Jarjoura, D. G., Ponzio, N. M., & Sanders, V. M. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.10.019 · Cited by 59
Hylander, B. L., Gordon, C. J., & Repasky, E. A. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800621 · Cited by 53
Self-citationβ2 Adrenergic receptor on T lymphocytes and its clinical implications
Fan, X.-L., & Wang, Y. (2008) · Progress in Natural Science Materials International · doi:10.1016/j.pnsc.2008.10.001 · Cited by 44
Mechanisms overseeing myeloid-derived suppressor cell production in neoplastic disease
Netherby, C. S., & Abrams, S. I. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-1963-5 · Cited by 41
Self-citationBlockade of Host β2-Adrenergic Receptor Enhances Graft-versus-Tumor Effect through Modulating APCs
Mohammadpour, H., O’Neil, R., Qiu, J., McCarthy, P. L., Repasky, E. A., & Cao, X. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701752 · Cited by 33
Self-citationPeyvandi, S., Buart, S., Samah, B., Vétizou, M., Zhang, Y., Durrieu, L., Polrot, M., Chouaïb, S., Benihoud, K., Louache, F., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1848 · Cited by 30
Cited by
The updated landscape of tumor microenvironment and drug repurposing
Jin, M.-Z., & Jin, W.-L. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00280-x · Cited by 1,262
Targeting STAT3 in Cancer Immunotherapy
Zou, S., Tong, Q., Liu, B., Huang, W., Tian, Y., & Fu, X. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01258-7 · Cited by 1,050
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
Li, K., Shi, H., Zhang, B., Ou, X., Ma, Q., Chen, Y., Shu, P., Li, D., & Wang, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00670-9 · Cited by 988
Turning cold tumors hot: from molecular mechanisms to clinical applications
Zhang, J., Huang, D., Saw, P. E., & Song, E. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.04.010 · Cited by 534
Cancer neuroscience: State of the field, emerging directions
Winkler, F., Venkatesh, H. S., Amit, M., Batchelor, T., Demir, I. E., Deneen, B., Gutmann, D. H., Hervey-Jumper, S., Kuner, T., Mabbott, D., et al. (2023) · Cell · doi:10.1016/j.cell.2023.02.002 · Cited by 552
Metadata
- Authors
- Mohammadpour, H., MacDonald, C. R., Qiao, G., Chen, M., Dong, B., Hylander, B. L., McCarthy, P. L., Abrams, S. I., & Repasky, E. A.
- Venue
- Journal of Clinical Investigation
- Published
- 2019-11-11
- Volume
- 129
- Issue
- 12
- Pages
- 5537-5552
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2978526767
- Cited by
- 320
- References
- 54
- FWCI
- 7.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.